CN111991286A - Eye cream composition for fading fine wrinkles and preparation method thereof - Google Patents

Eye cream composition for fading fine wrinkles and preparation method thereof Download PDF

Info

Publication number
CN111991286A
CN111991286A CN202010843608.6A CN202010843608A CN111991286A CN 111991286 A CN111991286 A CN 111991286A CN 202010843608 A CN202010843608 A CN 202010843608A CN 111991286 A CN111991286 A CN 111991286A
Authority
CN
China
Prior art keywords
parts
eye cream
cream composition
skin care
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010843608.6A
Other languages
Chinese (zh)
Inventor
骆正哲
钱英
骆承甫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Zhixin Biotechnology Co ltd
Original Assignee
Shanghai Zhixin Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Zhixin Biotechnology Co ltd filed Critical Shanghai Zhixin Biotechnology Co ltd
Priority to CN202010843608.6A priority Critical patent/CN111991286A/en
Publication of CN111991286A publication Critical patent/CN111991286A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/445Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The application discloses an eye cream composition for fading fine wrinkles and a preparation method thereof, and relates to the technical field of cosmetics. The technical key points are as follows: the eye cream composition for fading fine wrinkles comprises the following components in parts by weight: the functional substances are: acetyl hexapeptide-10.0025-0.005 part, yeast extract 0.5-1 part, dipalmitoyl hydroxyproline 0.1-0.2 part, sodium ascorbyl phosphate 1-2 parts, panthenol 1-2 parts, coffee chervil seed extract 0.2-0.5 part, cyclodextrin 0.2-0.5 part, aescin 0.1-0.3 part, European fructus valiae bud extract 0.1-0.2 part, hydroxyphenyl propionamide benzoic acid 0.05-0.1 part; anticorrosive material: 0.9-1.8 parts; emulsifying materials: 16.5-31.6 parts; skin care materials: 10.75-21.7 parts; deionized water: 40-50 parts. The eye cream composition prepared by the application has the advantages of delaying skin aging around eyes and fading fine wrinkles.

Description

Eye cream composition for fading fine wrinkles and preparation method thereof
Technical Field
The application relates to the technical field of cosmetics, in particular to an eye cream composition for fading fine wrinkles and a preparation method thereof.
Background
The eye skin is the thinnest skin of the human body and is the part which moves most frequently. Modern life style brings more harm and burden to eye skin, people work and live more and more with computers, and a large number of newspapers and magazines, video compact discs dominate leisure time, eyes and skin around the eyes are in a tense state for a long time, and eye fatigue, dry eyes and skin circulation around the eyes are easy to cause. Meanwhile, the long-time use of the heater and the air conditioner easily causes the skin to lack of water, the thickness of the epidermis and the corium layer of the eye skin is only 0.55mm, and the thickness of the epidermis and the corium layer of the eye skin is only one fourth of the thickness of the face skin, so that the problem of water shortage and dryness is more easily caused; frequent physical and chemical injuries caused by the use of color cosmetics such as eye shadow, eye liner and mascara and the removal of makeup used for eye makeup all make the eye skin of people more fragile and sensitive, so that a series of problems such as dark circles, fine lines, looseness and the like are more easily caused, and therefore, the selection of a proper eye care product is a necessary skin care procedure.
Most of the efficacy type eye care products in the market volatilize efficacy by adding active compounds, such as acetyl hexapeptide-8, tripeptide, tetrapeptide and the like, so that the application of a single component has weak efficacy, and the tissue structure of the eye skin cannot be comprehensively improved to comprehensively improve the skin condition of the eyes.
Therefore, a new solution is needed to solve the above problems.
Disclosure of Invention
Aiming at the problem that the existing eye cream on the market is single in function, the application aims to provide the eye cream composition for fading fine lines, which has the advantages of delaying skin aging around eyes and fading fine lines.
The second purpose of the present application is to provide a preparation method of an eye cream composition for fading fine wrinkles, which has the advantages of simple operation and suitability for large-scale production.
In order to achieve the first purpose, the application provides the following technical scheme:
an eye cream composition for fading fine wrinkles comprises the following components in parts by weight:
the functional substances are: acetyl hexapeptide-10.0025-0.005 part, yeast extract 0.5-1 part, dipalmitoyl hydroxyproline 0.1-0.2 part, sodium ascorbyl phosphate 1-2 parts, panthenol 1-2 parts, coffee chervil seed extract 0.2-0.5 part, cyclodextrin 0.2-0.5 part, aescin 0.1-0.3 part, European fructus valiae bud extract 0.1-0.2 part, hydroxyphenyl propionamide benzoic acid 0.05-0.1 part;
anticorrosive material: 0.9-1.8 parts;
emulsifying materials: 16.5-31.6 parts;
skin care materials: 10.75-21.7 parts;
deionized water: 40-50 parts.
By adopting the technical scheme, the ratio of acetyl hexapeptide-1: the botulinum toxin is a botulinum polypeptide, has the same wrinkle-removing effect as botulinum toxin injections (Botox injections), and has the effects of tightening and smoothing fine wrinkles by controlling various factors before and after synapse through multiple channels to relax facial muscles.
Yeast extract (B): the natural yeast essence is extracted and purified from saccharomyces cerevisiae, is rich in polypeptide, amino acid, nucleic acid and the like, has the functions of removing free radicals, protecting and improving cells, and achieves the effect of slowing down the generation of fine wrinkles.
Dipalmitoyl hydroxyproline: it is a hydroxyproline biological conductor, promotes collagen fiber contraction, protects elastic fiber, stimulates natural anti-aging inhibitors TIMPs, inhibits MMPs enzymes which play a promoting role in the skin aging process, protects dermal epidermis matrix and collagen, and achieves the effect of lightening fine lines.
Sodium ascorbyl phosphate: it is a vitamin C derivative, and can promote collagen synthesis, keep skin moisture, and prevent fine wrinkles.
Panthenol: the derivative of vitamin B5 can make skin plump, and helps to reduce the appearance of fine lines and wrinkles, and make skin feel smoother, firmer and more flexible. It is also thought to promote the formation of new skin cells and to prevent the formation of fine lines.
Extract of small fruit coffee seeds: it can control the problem of too high body fluid content among cells caused by cellulite, tighten skin, protect cells from ultraviolet radiation, protect fibroblasts, slow down the photoaging process of skin, and achieve the effect of slowing down the generation of fine wrinkles.
Aescin: the main active component of the horse chestnut is horse chestnut saponin which is a triterpenoid saponin compound and is a strong hemolytic saponin, the structure of the horse chestnut saponin compound is horse chestnut sapogenin + one part of synuclein +2 molecules of glucose, Rho can activate Rho kinase, promote the formation of actin and myosin, improve the contractility of the skin dermis part and achieve the effect of fading fine wrinkles.
Cyclobalanopsis glauca bud extract: it is an active substance rich in various high molecular weight hydrophilic compounds, such as polyphenols, glucoside, mineral salts, amino acids, etc. The skin care product can activate oxygen consumption of cells, improve energy storage in the cells, promote cell metabolism, accelerate skin renewal, and finally achieve the effects of enhancing skin barriers, moisturizing and tightening, and smoothening skin textures.
The hydroxyphenylpropionamide benzoic acid, also called as dihydrooat alkaloid, can exert multiple effects of resisting histamine, oxidation and irritation, resisting inflammation, improving erythema and the like, and has better effects on relieving pruritus, irritation, redness and the like of sensitive skin.
Compared with the traditional eye cream, the eye cream adopts multiple components to form an effective substance in a compounding way, and the eye cream product obtained from the clear effect mechanism of the active substance is safe, non-irritating and strong in pertinence, and achieves the effect of fading fine wrinkles through multiple target points.
More preferably, the eye cream composition for fading fine wrinkles comprises the following components in parts by weight:
the functional substances are: acetyl hexapeptide-10.003-0.0045 parts, yeast extract 0.7-0.8 parts, dipalmitoyl hydroxyproline 0.13-0.17 parts, sodium ascorbyl phosphate 1.4-1.6 parts, panthenol 1.4-1.6 parts, small fruit coffee seed extract 0.3-0.4 parts, cyclodextrin 0.3-0.4 parts, aescin 0.15-0.25 parts, European cyclobalanopsis glauca bud extract 0.14-0.16 parts, hydroxyphenyl propionamide benzoic acid 0.07-0.08 parts;
anticorrosive material: 1.2-1.6 parts;
emulsifying materials: 20-25 parts;
skin care materials: 15-17 parts;
deionized water: 44-46 parts.
More preferably, the eye cream composition for fading fine wrinkles comprises the following components in parts by weight:
the functional substances are: 10.004 parts of acetyl hexapeptide, 0.75 part of yeast extract, 0.15 part of dipalmitoyl hydroxyproline, 1.5 parts of sodium ascorbyl phosphate, 1.5 parts of panthenol, 0.35 part of small-fruit coffee seed extract, 0.35 part of cyclodextrin, 0.2 part of aescin, 0.15 part of European cyclobalanopsis glauca bud extract and 0.075 part of hydroxyphenylpropionamide benzoic acid;
anticorrosive material: 1.35 parts;
emulsifying materials: 24.5 parts;
skin care materials: 16.5 parts of;
deionized water: 45 parts of the raw materials.
Further preferably, the anticorrosive material comprises the following components in parts by weight: 0.2-0.5 part of p-hydroxyacetophenone, 0.5-1 part of 1, 2-hexanediol and 0.1-0.3 part of ethylhexyl glycerol.
Through adopting above-mentioned technical scheme, with the cosmetic contrast on the current market, the multiple antiseptic that this application adopted, its anticorrosive effectual and do not have any safety problem.
Further preferably, the emulsified material comprises the following components in parts by weight: 4-8 parts of cyclopentacarylene dimethyl siloxane, 110.5-1 parts of polysiloxane, 3-5 parts of hydrogenated polyisobutene, 3-5 parts of caprylic/capric triglyceride, 1-2 parts of behenyl alcohol, 1-2 parts of shea butter, 1-2 parts of polydimethylsiloxane, 1-2 parts of stearyl polydimethylsiloxane, 0.1-0.3 part of stearyl glycyrrhetinate, 0.1-0.3 part of phytosterol isostearate, 0.1-0.5 part of beeswax, 1-2 parts of PEG-100 stearate, 0.5-1 part of glyceryl stearate, 0.1-0.3 part of PEG/PPG-18/18 polydimethylsiloxane and 0.1-0.2 part of hydrogenated lecithin.
By adopting the technical scheme, a plurality of substances with emulsification and substances which can promote the absorption of other substances to the skin are compounded for use, and the obtained eye cream product is easy to absorb and is not greasy, and has better ductility and refreshing feeling when being applied to eyes.
Further preferably, the skin care material comprises the following components in parts by weight: 4-8 parts of glycerol, 4-8 parts of 1, 3-propylene glycol, 0.5-1 part of acacia gum, 0.5-1 part of rhizobia gel, 1-2 parts of trehalose, 0.05-0.1 part of hydroxypropyl dipalmitylamide MEA, 0.1-0.2 part of hyaluronic acid, 0.1-0.2 part of allantoin, 0.1-0.2 part of sclerotium rolfsii gel, 0.2-0.5 part of sodium citrate and 0.2-0.5 part of citric acid.
By adopting the technical scheme, the components are matched with each other for use, so that the eye cream has better moisturizing capability and has the effect of promoting the skin to absorb functional substances better.
In order to achieve the second purpose, the application provides the following technical scheme:
a preparation method of an eye cream composition for fading fine lines comprises the following steps:
s1, respectively putting the functional substance, the skin care material and the emulsified material into 3 different mixers, adding 1/3 deionized water into the mixer containing the functional substance and the skin care material, and uniformly stirring;
s2, heating the skin care material and the emulsifying material in a mixer to 60-80 ℃ respectively until all the materials are dissolved, adding the emulsifying material into the skin care material, adding the uniformly mixed preservative material and the rest water, vacuumizing, filtering, and emulsifying after filtering;
s3, heating the mixer where the skin care material is in to 80-90 ℃, stirring at the rotation speed of 500-700rpm for 30min, cooling to 40 ℃, adding the functional substance, stirring at the rotation speed of 400-600rpm for 30-45min, and defoaming in vacuum;
and S4, discharging, filling, packaging and warehousing after the inspection is qualified.
By adopting the technical scheme, the preparation method provided by the application is simple to operate, the preparation process is safer, and the preparation method is suitable for large-scale production.
Drawings
Fig. 1 is a flow chart of a process for preparing a fine-line lightening eye cream composition according to example 1 of the present application.
Detailed Description
The present application will be described in detail below with reference to the drawings and examples.
Example 1: the fine line fading eye cream composition is prepared by the following steps, wherein the components and the corresponding parts by weight are shown in table 1, and the eye cream composition is prepared by referring to fig. 1:
s1, respectively putting the functional substance, the skin care material and the emulsified material into 3 different mixers, adding 1/3 deionized water into the mixer containing the functional substance and the skin care material, and uniformly stirring;
s2, heating the skin care material and the emulsifying material in a mixer to 60 ℃ and 65 ℃ respectively until all the materials are dissolved, adding the emulsifying material into the skin care material, adding the uniformly mixed anticorrosive material and the rest deionized water, vacuumizing, filtering, and performing conventional emulsification;
s3, heating the skin care material in a mixer to 80 ℃, stirring at 500rpm for 30min, cooling to 40 ℃, adding an effective substance, stirring at 400rpm for 45min, and defoaming in vacuum at-0.09 MPa;
and S4, discharging, filling, packaging and warehousing after the inspection is qualified.
Examples 2 to 6: an eye cream composition for reducing fine wrinkles, which is different from example 1 in that each component and corresponding parts by weight thereof are shown in table 1.
TABLE 1 Components and parts by weight of examples 1-6
Figure BDA0002642296160000051
Figure BDA0002642296160000061
Example 7: an eye cream composition for reducing fine wrinkles, which is different from example 1 in that it is prepared by the following steps:
s1, respectively putting the functional substance, the skin care material and the emulsified material into 3 different mixers, adding 1/3 deionized water into the mixer containing the functional substance and the skin care material, and uniformly stirring;
s2, heating the skin care material and the emulsifying material in a mixer to 75 ℃ and 80 ℃ respectively until all the materials are dissolved, adding the emulsifying material into the skin care material, adding the uniformly mixed anticorrosive material and the rest deionized water, vacuumizing, filtering, and performing conventional emulsification;
s3, heating the skin care material in a mixer to 90 ℃, stirring at 700rpm for 30min, cooling to 40 ℃, adding an effective substance, stirring at 600rpm for 30min, and defoaming in vacuum at-0.09 MPa;
and S4, discharging, filling, packaging and warehousing after the inspection is qualified.
Comparative example 1: an eye cream composition, which is different from example 1 in that a certain brand 1, which is generally commercially available, is used as comparative example 1.
Comparative example 2: an eye cream composition, which is different from example 1 in that a certain brand 2, which is generally commercially available, is used as comparative example 2.
Comparative example 3: an eye cream composition was different from example 1 in that a certain brand 3, which is generally commercially available, was used as comparative example 3.
Performance testing
The eye cream compositions obtained in examples 1 to 7 and comparative examples 1 to 3 were subjected to performance tests, respectively.
Test objects: 100 volunteers of 40-65 years old are divided into 10 groups.
The test method comprises the following steps: volunteers were allowed to use the eye cream compositions of examples 1 to 7 and comparative examples 1 to 31 time each day in the morning and evening, and evaluation was performed after 2 months of use, and the evaluation results were included in the following table 2.
Grading standard: 5 min-very good; 4 min-better; 3 min-general; 2 min-poor; 1 min-very poor.
As can be seen from the test data in table 2, compared with the three types of eye cream products sold in the market, the eye cream compositions in examples 1 to 7 in the present application have better sensory evaluation, and are good in user experience and comfortable to use. The eye creams of examples 1-7 all improved the skin around the eyes to a very high degree, and the subjects showed a firm, firm and elastic skin and a high improvement of fine wrinkles after using the eye cream product of this application.
Table 2 results of performance testing
Figure BDA0002642296160000071
The above description is only a preferred embodiment of the present application, and the protection scope of the present application is not limited to the above embodiments, and all technical solutions belonging to the idea of the present application belong to the protection scope of the present application. It should be noted that several improvements and modifications to the present application without departing from the principles of the present application will occur to those skilled in the art, and such improvements and modifications should also be considered within the scope of the present application.

Claims (7)

1. The eye cream composition for fading fine wrinkles is characterized by comprising the following components in parts by weight:
the functional substances are: acetyl hexapeptide-10.0025-0.005 part, yeast extract 0.5-1 part, dipalmitoyl hydroxyproline 0.1-0.2 part, sodium ascorbyl phosphate 1-2 parts, panthenol 1-2 parts, coffee chervil seed extract 0.2-0.5 part, cyclodextrin 0.2-0.5 part, aescin 0.1-0.3 part, European fructus valiae bud extract 0.1-0.2 part, hydroxyphenyl propionamide benzoic acid 0.05-0.1 part;
anticorrosive material: 0.9-1.8 parts;
emulsifying materials: 16.5-31.6 parts;
skin care materials: 10.75-21.7 parts;
deionized water: 40-50 parts.
2. The fine line fading eye cream composition according to claim 1, which is characterized by comprising the following components in parts by weight:
the functional substances are: acetyl hexapeptide-10.003-0.0045 parts, yeast extract 0.7-0.8 parts, dipalmitoyl hydroxyproline 0.13-0.17 parts, sodium ascorbyl phosphate 1.4-1.6 parts, panthenol 1.4-1.6 parts, small fruit coffee seed extract 0.3-0.4 parts, cyclodextrin 0.3-0.4 parts, aescin 0.15-0.25 parts, European cyclobalanopsis glauca bud extract 0.14-0.16 parts, hydroxyphenyl propionamide benzoic acid 0.07-0.08 parts;
anticorrosive material: 1.2-1.6 parts;
emulsifying materials: 20-25 parts;
skin care materials: 15-17 parts;
deionized water: 44-46 parts.
3. The fine line fading eye cream composition according to claim 2, which is characterized by comprising the following components in parts by weight:
the functional substances are: 10.004 parts of acetyl hexapeptide, 0.75 part of yeast extract, 0.15 part of dipalmitoyl hydroxyproline, 1.5 parts of sodium ascorbyl phosphate, 1.5 parts of panthenol, 0.35 part of small coffee seed extract, 0.35 part of cyclodextrin, 0.2 part of aescin, 0.15 part of European cyclobalanopsis glauca bud extract and 0.075 part of hydroxyphenylpropionamide benzoic acid;
anticorrosive material: 1.35 parts;
emulsifying materials: 24.5 parts;
skin care materials: 16.5 parts of;
deionized water: 45 parts of the raw materials.
4. The fine line fading eye cream composition according to claim 3, wherein the anticorrosive material comprises, in parts by weight: 0.2-0.5 part of p-hydroxyacetophenone, 0.5-1 part of 1, 2-hexanediol and 0.1-0.3 part of ethylhexyl glycerol.
5. The fine line fading eye cream composition according to claim 3, wherein the emulsion material comprises, in parts by weight: 4-8 parts of cyclopentacalydimethylsiloxane, 110.5-1 parts of polysiloxane, 3-5 parts of hydrogenated polyisobutene, 3-5 parts of caprylic/capric triglyceride, 1-2 parts of behenyl alcohol, 1-2 parts of shea butter, 1-2 parts of polydimethylsiloxane, 1-2 parts of stearyl polydimethylsiloxane, 0.1-0.3 part of stearyl glycyrrhetinate, 0.1-0.3 part of phytosterol isostearate, 0.1-0.5 part of beeswax, 1-2 parts of PEG-100 stearate, 0.5-1 part of glyceryl stearate, 0.1-0.3 part of PEG/PPG-18/18 polydimethylsiloxane and 0.1-0.2 part of hydrogenated lecithin.
6. The fine line reduction eye cream composition according to claim 3, wherein the skin care material comprises, in parts by weight: 4-8 parts of glycerol, 4-8 parts of 1, 3-propylene glycol, 0.5-1 part of acacia gum, 0.5-1 part of rhizobia gel, 1-2 parts of trehalose, 0.05-0.1 part of hydroxypropyl dipalmitylamide MEA, 0.1-0.2 part of hyaluronic acid, 0.1-0.2 part of allantoin, 0.1-0.2 part of sclerotium rolfsii gel, 0.2-0.5 part of sodium citrate and 0.2-0.5 part of citric acid.
7. A method of preparing a fine line reducing eye cream composition according to any one of claims 1 to 6, comprising the steps of:
s1, respectively putting the functional substance, the skin care material and the emulsified material into 3 different mixers, adding 1/3 deionized water into the mixer containing the functional substance and the skin care material, and uniformly stirring;
s2, heating the skin care material and the emulsifying material in a mixer to 60-80 ℃ respectively until all the materials are dissolved, adding the emulsifying material into the skin care material, adding the uniformly mixed preservative material and the rest water, vacuumizing, filtering, and emulsifying after filtering;
s3, heating the mixer where the skin care material is in to 80-90 ℃, stirring at the rotation speed of 500-700rpm for 30min, cooling to 40 ℃, adding the functional substance, stirring at the rotation speed of 400-600rpm for 30-45min, and defoaming in vacuum;
and S4, discharging, filling, packaging and warehousing after the inspection is qualified.
CN202010843608.6A 2020-08-20 2020-08-20 Eye cream composition for fading fine wrinkles and preparation method thereof Pending CN111991286A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010843608.6A CN111991286A (en) 2020-08-20 2020-08-20 Eye cream composition for fading fine wrinkles and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010843608.6A CN111991286A (en) 2020-08-20 2020-08-20 Eye cream composition for fading fine wrinkles and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111991286A true CN111991286A (en) 2020-11-27

Family

ID=73472249

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010843608.6A Pending CN111991286A (en) 2020-08-20 2020-08-20 Eye cream composition for fading fine wrinkles and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111991286A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113018232A (en) * 2021-03-10 2021-06-25 福建师范大学 Eye cream containing hibiscus flower extract and preparation method thereof
CN113893215A (en) * 2021-10-09 2022-01-07 广州市涵美化妆品有限公司 Eye tightening and repairing composition, application, eye cream and preparation method thereof
CN117224452A (en) * 2023-11-15 2023-12-15 露乐健康科技股份有限公司 Mild skin care composition containing plant bud extract and its application in guarding skin barrier

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309349A (en) * 2016-09-30 2017-01-11 广东丸美生物技术股份有限公司 Compound for removing black eye and relieving wrinkles, preparation method and application thereof
CN108969444A (en) * 2018-09-19 2018-12-11 陈洁珍 One kind removing black eye, crease-resistant Firm anti-age corrective eye treatment cream and preparation method thereof
CN109276509A (en) * 2018-12-18 2019-01-29 珠海水信生物科技有限公司 A kind of compact eye cream of multiple-effect
CN109528595A (en) * 2018-12-29 2019-03-29 广州睿森生物科技有限公司 A kind of plant composition for skin care and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106309349A (en) * 2016-09-30 2017-01-11 广东丸美生物技术股份有限公司 Compound for removing black eye and relieving wrinkles, preparation method and application thereof
CN108969444A (en) * 2018-09-19 2018-12-11 陈洁珍 One kind removing black eye, crease-resistant Firm anti-age corrective eye treatment cream and preparation method thereof
CN109276509A (en) * 2018-12-18 2019-01-29 珠海水信生物科技有限公司 A kind of compact eye cream of multiple-effect
CN109528595A (en) * 2018-12-29 2019-03-29 广州睿森生物科技有限公司 A kind of plant composition for skin care and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王建新: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113018232A (en) * 2021-03-10 2021-06-25 福建师范大学 Eye cream containing hibiscus flower extract and preparation method thereof
CN113893215A (en) * 2021-10-09 2022-01-07 广州市涵美化妆品有限公司 Eye tightening and repairing composition, application, eye cream and preparation method thereof
CN113893215B (en) * 2021-10-09 2023-08-08 广州市涵美化妆品有限公司 Eye tightening and repairing composition, application and eye cream and preparation method thereof
CN117224452A (en) * 2023-11-15 2023-12-15 露乐健康科技股份有限公司 Mild skin care composition containing plant bud extract and its application in guarding skin barrier
CN117224452B (en) * 2023-11-15 2024-03-22 露乐健康科技股份有限公司 Mild skin care composition containing plant bud extract and its application in guarding skin barrier

Similar Documents

Publication Publication Date Title
CN111904906B (en) Composition for repairing skin barrier and improving skin resistance and preparation method thereof
KR102265730B1 (en) cosmetic composition for skin wrinkle improvement and whitening facial skin
CN111991286A (en) Eye cream composition for fading fine wrinkles and preparation method thereof
CN113648235B (en) Composition for immediately removing wrinkles, eye mask essence, wrinkle-removing cosmetic and application
US20170151171A1 (en) Cosmetic composition for anti-aging
CN107334726B (en) Acne-removing composition and preparation method and application thereof
CN107308063B (en) Anti-wrinkle eye lotion and preparation method thereof
CN111000748A (en) Polypeptide repairing cream and preparation method thereof
CN109953926B (en) Skin care product with five-vitamin anti-wrinkle and anti-aging effects and preparation method thereof
CN113288822B (en) Multi-dimensional anti-wrinkle composition, cosmetic composition and preparation method of cosmetic composition
CN111939116A (en) Anti-aging composition and preparation method thereof
CN113398016A (en) Skin soothing and repairing composition and cosmetic composition
CN111973508A (en) Anti-aging composition capable of relieving and moisturizing
CN111686068A (en) Anti-wrinkle skin-activating cream and preparation method thereof
CN110538093A (en) polypeptide repair liquid and preparation method thereof
CN110393689A (en) It is a kind of to have effects that anti-ageing essence composition and preparation method thereof
CN114588061A (en) Anti-aging and wrinkle-removing composition, preparation method thereof and skin care product
CN112773761B (en) Cosmetic composition, essence and preparation method thereof
CN113952277A (en) Microcrystalline peptide anti-wrinkle face cream and preparation method thereof
CN113081942A (en) Multi-dimensional hydration cream containing apple stem cells
CN112043659A (en) Anti-wrinkle repair essence cream
CN115414293B (en) Anti-aging composition and application thereof
CN114712285B (en) Composition with anti-wrinkle effect and preparation method and application thereof
CN115475131A (en) Moisturizing and elastic anti-wrinkle mask and preparation method thereof
CN114159333A (en) Muscle foundation liquid and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201127

RJ01 Rejection of invention patent application after publication